Brivaracetam NDC 14335-420

NDC codes

FDA NDC Directory

Product NDC (as listed)14335-420Labeler and product segments. Claims need a package NDC.

Product NDC at billing width14335-0420Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
14335-420-10	14335042010	10 VIAL, GLASS in 1 CARTON (14335-420-10) / 5 mL in 1 VIAL, GLASS (14335-420-01)Marketed from Feb 21, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brivaracetam
Generic name (nonproprietary): brivaracetam
Active ingredients: Brivaracetam — 50 mg/5mL
Dosage form: Injection
Route: Intravenous
Labeler: Hainan Poly Pharm. Co., Ltd.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218249
Marketing start: Feb 21, 2026
Listing expires: Dec 31, 2027
DEA schedule: CV
Other FDA classes: Epoxide Hydrolase Inhibitors (Mechanism)
Identifiers: Product ID 14335-420_4a887373-339e-1795-e063-6394a90a17dcSPL ID 4a887373-339e-1795-e063-6394a90a17dcSPL set ID 3ea51292-fe03-46f5-9d9b-36986f5b7224RxCUI 1739749UNII U863JGG2IAUPC 0314335420106

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N414335042010 followed by a unit qualifier and the quantity

Package 14335-0420-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 23, 2026.

Indications (excerpt from the label)

Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218249

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218249
Product	Strength	Form · route	Labeler	Product NDC
Brivaracetambrivaracetam injection	Brivaracetam 50 mg/5mL	InjectionIntravenous	PAI Holdings, LLC dba PAI Pharma	0121-1075